CN115813882A - A method for enhancing absorption of vitamins and minerals in intestinal tract - Google Patents
A method for enhancing absorption of vitamins and minerals in intestinal tract Download PDFInfo
- Publication number
- CN115813882A CN115813882A CN202211555869.3A CN202211555869A CN115813882A CN 115813882 A CN115813882 A CN 115813882A CN 202211555869 A CN202211555869 A CN 202211555869A CN 115813882 A CN115813882 A CN 115813882A
- Authority
- CN
- China
- Prior art keywords
- vitamin
- polyphenol
- vitamins
- solution
- soluble
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229940088594 vitamin Drugs 0.000 title claims abstract description 159
- 229930003231 vitamin Natural products 0.000 title claims abstract description 159
- 239000011782 vitamin Substances 0.000 title claims abstract description 159
- 235000013343 vitamin Nutrition 0.000 title claims abstract description 158
- 239000011707 mineral Substances 0.000 title claims abstract description 51
- 229910052500 inorganic mineral Inorganic materials 0.000 title claims abstract description 50
- 238000010521 absorption reaction Methods 0.000 title claims abstract description 37
- 210000001035 gastrointestinal tract Anatomy 0.000 title claims abstract description 27
- 238000000034 method Methods 0.000 title claims abstract description 23
- 230000002708 enhancing effect Effects 0.000 title claims abstract description 11
- 150000003722 vitamin derivatives Chemical class 0.000 claims abstract description 75
- 235000013824 polyphenols Nutrition 0.000 claims abstract description 58
- 150000008442 polyphenolic compounds Chemical class 0.000 claims abstract description 56
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 30
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 27
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 24
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 claims abstract description 18
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 claims abstract description 18
- 229940030275 epigallocatechin gallate Drugs 0.000 claims abstract description 18
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 15
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 15
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 15
- 229940046009 vitamin E Drugs 0.000 claims abstract description 15
- 239000011709 vitamin E Substances 0.000 claims abstract description 15
- 239000000463 material Substances 0.000 claims abstract description 13
- 229940045997 vitamin a Drugs 0.000 claims abstract description 13
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 12
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 12
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 12
- 239000011718 vitamin C Substances 0.000 claims abstract description 12
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims abstract description 10
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims abstract description 10
- 229930003316 Vitamin D Natural products 0.000 claims abstract description 9
- 235000019166 vitamin D Nutrition 0.000 claims abstract description 9
- 239000011710 vitamin D Substances 0.000 claims abstract description 9
- 150000003710 vitamin D derivatives Chemical class 0.000 claims abstract description 9
- 229940046008 vitamin d Drugs 0.000 claims abstract description 9
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 claims abstract description 7
- 239000001263 FEMA 3042 Substances 0.000 claims abstract description 7
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 claims abstract description 7
- 229920002258 tannic acid Polymers 0.000 claims abstract description 7
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 claims abstract description 7
- 235000015523 tannic acid Nutrition 0.000 claims abstract description 7
- 229940033123 tannic acid Drugs 0.000 claims abstract description 7
- -1 vitamin compound Chemical class 0.000 claims abstract description 7
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims abstract description 5
- 229960000304 folic acid Drugs 0.000 claims abstract description 5
- 235000019152 folic acid Nutrition 0.000 claims abstract description 5
- 239000011724 folic acid Substances 0.000 claims abstract description 5
- 230000014759 maintenance of location Effects 0.000 claims abstract description 5
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 claims abstract description 4
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 claims abstract description 4
- 229960002079 calcium pantothenate Drugs 0.000 claims abstract description 4
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 claims abstract description 4
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 claims abstract description 4
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 claims abstract description 4
- 235000005493 rutin Nutrition 0.000 claims abstract description 4
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 claims abstract description 4
- 229960004555 rutoside Drugs 0.000 claims abstract description 4
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims abstract description 3
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims abstract description 3
- 229930003779 Vitamin B12 Natural products 0.000 claims abstract description 3
- 229930003471 Vitamin B2 Natural products 0.000 claims abstract description 3
- 229960002477 riboflavin Drugs 0.000 claims abstract description 3
- 235000019163 vitamin B12 Nutrition 0.000 claims abstract description 3
- 239000011715 vitamin B12 Substances 0.000 claims abstract description 3
- 235000019164 vitamin B2 Nutrition 0.000 claims abstract description 3
- 239000011716 vitamin B2 Substances 0.000 claims abstract description 3
- 239000000243 solution Substances 0.000 claims description 39
- 241000196324 Embryophyta Species 0.000 claims description 25
- 239000003921 oil Substances 0.000 claims description 13
- 235000019198 oils Nutrition 0.000 claims description 12
- 239000000839 emulsion Substances 0.000 claims description 11
- 229910021642 ultra pure water Inorganic materials 0.000 claims description 10
- 239000012498 ultrapure water Substances 0.000 claims description 10
- 238000002156 mixing Methods 0.000 claims description 9
- 150000003839 salts Chemical class 0.000 claims description 8
- 239000008055 phosphate buffer solution Substances 0.000 claims description 7
- 239000011701 zinc Substances 0.000 claims description 7
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- 239000002105 nanoparticle Substances 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- 238000009210 therapy by ultrasound Methods 0.000 claims description 5
- 238000005054 agglomeration Methods 0.000 claims description 4
- 230000002776 aggregation Effects 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 4
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical compound [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 claims description 3
- 235000010208 anthocyanin Nutrition 0.000 claims description 3
- 239000004410 anthocyanin Substances 0.000 claims description 3
- 229930002877 anthocyanin Natural products 0.000 claims description 3
- 150000004636 anthocyanins Chemical class 0.000 claims description 3
- 229910001448 ferrous ion Inorganic materials 0.000 claims description 3
- 238000004108 freeze drying Methods 0.000 claims description 3
- 239000012535 impurity Substances 0.000 claims description 3
- 235000012424 soybean oil Nutrition 0.000 claims description 3
- 239000003549 soybean oil Substances 0.000 claims description 3
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 claims description 2
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 claims description 2
- 238000005520 cutting process Methods 0.000 claims description 2
- 238000001179 sorption measurement Methods 0.000 claims description 2
- 229910021645 metal ion Inorganic materials 0.000 abstract description 14
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 abstract description 11
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 abstract description 11
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 abstract description 11
- 235000019155 vitamin A Nutrition 0.000 abstract description 11
- 239000011719 vitamin A Substances 0.000 abstract description 11
- 230000000968 intestinal effect Effects 0.000 abstract description 10
- 239000000126 substance Substances 0.000 abstract description 9
- 102000018697 Membrane Proteins Human genes 0.000 abstract description 2
- 108010052285 Membrane Proteins Proteins 0.000 abstract description 2
- 230000000536 complexating effect Effects 0.000 abstract description 2
- 230000003993 interaction Effects 0.000 abstract description 2
- 229930014669 anthocyanidin Natural products 0.000 abstract 1
- 150000001452 anthocyanidin derivatives Chemical class 0.000 abstract 1
- 235000008758 anthocyanidins Nutrition 0.000 abstract 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 abstract 1
- 235000010755 mineral Nutrition 0.000 description 34
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 24
- 239000002245 particle Substances 0.000 description 12
- 241000700159 Rattus Species 0.000 description 11
- 239000008280 blood Substances 0.000 description 11
- 210000004369 blood Anatomy 0.000 description 11
- 238000002360 preparation method Methods 0.000 description 9
- 230000004048 modification Effects 0.000 description 8
- 238000012986 modification Methods 0.000 description 8
- 235000016709 nutrition Nutrition 0.000 description 7
- 239000003814 drug Substances 0.000 description 6
- 230000035764 nutrition Effects 0.000 description 6
- 239000013589 supplement Substances 0.000 description 6
- 229940079593 drug Drugs 0.000 description 5
- 235000015097 nutrients Nutrition 0.000 description 5
- 230000000694 effects Effects 0.000 description 4
- 210000003405 ileum Anatomy 0.000 description 4
- 210000001630 jejunum Anatomy 0.000 description 4
- 235000020786 mineral supplement Nutrition 0.000 description 4
- 229940029985 mineral supplement Drugs 0.000 description 4
- 229920001864 tannin Polymers 0.000 description 4
- 235000018553 tannin Nutrition 0.000 description 4
- 239000001648 tannin Substances 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 3
- 230000002209 hydrophobic effect Effects 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000008363 phosphate buffer Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- WQGWDDDVZFFDIG-UHFFFAOYSA-N pyrogallol Chemical compound OC1=CC=CC(O)=C1O WQGWDDDVZFFDIG-UHFFFAOYSA-N 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 241000776450 PVC group Species 0.000 description 2
- 229930003270 Vitamin B Chemical group 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000002224 dissection Methods 0.000 description 2
- 238000002296 dynamic light scattering Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 210000004051 gastric juice Anatomy 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 150000002500 ions Chemical group 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 230000001788 irregular Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 150000003384 small molecules Chemical class 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 235000019156 vitamin B Nutrition 0.000 description 2
- 239000011720 vitamin B Chemical group 0.000 description 2
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- 208000036649 Dysbacteriosis Diseases 0.000 description 1
- 208000027244 Dysbiosis Diseases 0.000 description 1
- 206010017943 Gastrointestinal conditions Diseases 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 238000003917 TEM image Methods 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 229920001222 biopolymer Polymers 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical group OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 description 1
- 230000009920 chelation Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000007910 chewable tablet Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000010668 complexation reaction Methods 0.000 description 1
- 239000011258 core-shell material Substances 0.000 description 1
- 229960000956 coumarin Drugs 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000007140 dysbiosis Effects 0.000 description 1
- 235000018927 edible plant Nutrition 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 239000011790 ferrous sulphate Substances 0.000 description 1
- 235000003891 ferrous sulphate Nutrition 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 230000002519 immonomodulatory effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000031891 intestinal absorption Effects 0.000 description 1
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N iron oxide Inorganic materials [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000037345 metabolism of vitamins Effects 0.000 description 1
- 239000002923 metal particle Substances 0.000 description 1
- 239000007935 oral tablet Substances 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 150000003891 oxalate salts Chemical class 0.000 description 1
- NDLPOXTZKUMGOV-UHFFFAOYSA-N oxo(oxoferriooxy)iron hydrate Chemical compound O.O=[Fe]O[Fe]=O NDLPOXTZKUMGOV-UHFFFAOYSA-N 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229930000223 plant secondary metabolite Natural products 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 229940079877 pyrogallol Drugs 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000006479 redox reaction Methods 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 238000001338 self-assembly Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000004627 transmission electron microscopy Methods 0.000 description 1
- 230000007723 transport mechanism Effects 0.000 description 1
- 238000002371 ultraviolet--visible spectrum Methods 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
- 235000005282 vitamin D3 Nutrition 0.000 description 1
- 239000011647 vitamin D3 Substances 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940021056 vitamin d3 Drugs 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 235000019195 vitamin supplement Nutrition 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Images
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The invention discloses a method for enhancing the absorption of vitamins and mineral substances in intestinal tracts, which comprises the steps of complexing plant polyphenol and mineral substances to form a nano-network material, and combining the nano-network material with vitamin molecules to form a polyphenol-based vitamin compound; the polyphenol-based vitamin complex has long retention time in intestinal tract, and can promote the absorption of vitamins and minerals in intestinal tract. The mineral is Zn 2+ Or Fe 2+ . The plant polyphenol is one of tannic acid, epigallocatechin gallate, rutin, and anthocyanidin. The vitamins are selected from one or more of oil soluble vitamin A, vitamin D, and vitamin E, or one or more of water soluble vitamin C, vitamin B2, vitamin B12, calcium pantothenate, and folic acid. The invention utilizes plant polyphenol and metal ions to modify vitamin molecules, constructs an effective vitamin intestinal delivery system, and utilizes the interaction of the plant polyphenol and intestinal wall cell surface protein to enhance the absorption of vitamins and minerals.
Description
Technical Field
The invention relates to the technical field of vitamin delivery, in particular to a method for enhancing the absorption of vitamins and minerals in intestinal tracts.
Background
Vitamins are a kind of nutrient substances necessary for maintaining body health, are low molecular organic compounds, and have very important effects on metabolism, growth, development and health of human and animal organisms. Minerals are a class of inorganic salts that, although less than 5% of the body weight is present in the human body, do not provide energy, but also play an important role in the physiological actions of human tissues.
Vitamins are a class of organic substances that are essential to the maintenance of human life and can only be obtained from food, and are classified into oil-soluble and water-soluble. Common oil-soluble vitamins are Vitamin A (VA), vitamin D (VD) and Vitamin E (VE). The water-soluble vitamins include Vitamin C (VC), vitamin B group such as B2, B5 (calcium pantothenate), B9 (folic acid), and B12. Supplements and products for vitamins and minerals in the market are of various brands and varieties. Under the call of modern nutrition advocating 'diversification', the composite supplement is popular with vitamin-nutrient mineral nutritional supplements. However, the prior product has serious technical homogeneity, is mainly subjected to iterative updating on formulas, namely the types and the dosages of vitamins and minerals, has the problems of insufficient additive dosage or excessive dosage, and does not fundamentally solve the problems of absorption and utilization rate of the vitamins. Apart from a balanced match, absorption is the key to the use of vitamins and minerals.
Oil-soluble vitamins can be analogized to common hydrophobic drugs. The delivery of hydrophobic drugs, the manner of preparation of oral formulations, can be applied to oil-soluble vitamin applications. It is challenging to deliver water-soluble vitamins. Water-soluble vitamins are generally administered in the form of chewable tablets, oral tablets, or granules. Such formulations require rapid disintegration of the dosage form when exposed to water to render the vitamin as water soluble as possible. The vitamins dissolved in water are small molecules which are free in the solution, and due to good reducibility, the vitamins are easily oxidized and decomposed by other substances and cannot be fully absorbed and utilized. The polarity of hydrophobic drugs is not suitable for the processing of water-soluble drugs. Therefore, improving the delivery and absorption efficiency of water-soluble vitamin molecules is key to effective vitamin supplementation. In addition, the existing products are all prepared into tablets or granules by blending different vitamins, and the antagonism among different vitamins is not considered. For example, large amounts of vitamin E consume vitamin a stores in the human body; vitamin C and vitamin B are easy to generate oxidation-reduction reaction, so that the vitamins lose efficacy; vitamin C and folic acid should be used off peak; the presence of large amounts of vitamin E can affect the absorption of vitamin K.
There are reports in the literature of modifications to fat-soluble and water-soluble vitamins, respectively. For example, patents CN113727706a and CN113747886a, select some biopolymers, such as alginate, chitosan, pectin, cyclodextrin, etc. These substances protect vitamins, are stable in the gastric acid environment and decompose in the intestinal environment. These materials and techniques enable the delivery of vitamins in the intestinal tract. However, these materials have not been shown to aid in the absorption of vitamins in the gut; only a sufficient absorption, vitamin and mineral supplement is of interest.
For the supplement of the minerals iron and zinc, the metal salts such as ferrous sulfate or the oxides such as zinc oxide are mainly used in the market at present. The metal salt and the oxide are fully dissolved in gastric juice to form an ion form and then enter the intestinal tract for absorption. However, this method is not efficient in mineral absorption. In gastric juice and intestinal juice, various digestive enzymes and substances produced by metabolism of other nutrients are usually present, and the substances are easy to react with the metal ions to regenerate water-insoluble metal salts, such as oxalates, so that the metal ions are rapidly precipitated and directly discharged out of the body without being absorbed. Therefore, the absorption of metal ions is effectively improved, and the mineral supplement is very important.
The gastrointestinal tract is an important site for vitamin absorption, and both vitamins and minerals are absorbed into the blood through a unique transport mechanism of intestinal wall cells. Due to the acceleration of modern life rhythm, irregular diet, diseases, treatment medicines and dysbacteriosis, intestinal tract reaction can be caused, the normal function of epithelial cells on the intestinal wall is influenced, and the absorption of vitamins is seriously hindered. Currently there is no effective way to specifically target the enhanced intestinal absorption of vitamins and minerals.
Disclosure of Invention
In order to enhance the absorption of vitamins and minerals in the gastrointestinal tract, the present invention provides a method for enhancing the absorption of vitamins and minerals in the gastrointestinal tract.
The method for enhancing the absorption of vitamins and minerals in the gastrointestinal tract provided by the invention utilizes plant Polyphenol and minerals to complex to form a nano-network Material (MPN), the nano-network material is combined with vitamin molecules, and a Polyphenol-based vitamin complex (PVC) is formed by coating or agglomeration adsorption. The polyphenol-based vitamin complex has long retention time in the gastrointestinal tract, and can promote the absorption of vitamins and minerals in the gastrointestinal tract.
The plant polyphenol is one of tannin, epigallocatechin gallate, rutin, and anthocyanins.
The mineral is Zn ion 2+ Or ferrous ion Fe 2+ 。
The method is suitable for oil-soluble vitamins and water-soluble vitamins. The oil soluble vitamin may be one or more of vitamin A, vitamin D, and vitamin E. The water soluble vitamin can be one or more of vitamin C, vitamin B2, vitamin B12, calcium pantothenate, and folic acid.
Aiming at oil-soluble vitamins, the preparation method of the polyphenol-based vitamin complex comprises the following steps:
(1) Dissolving vitamins in soybean oil to prepare an oil agent, and adding the oil agent into a phosphate buffer solution for ultrasonic treatment to form a vitamin emulsion;
(2) Dissolving plant polyphenol in ultrapure water to form a polyphenol water solution; and will contain Zn 2+ Or Fe 2+ Dissolving the soluble salt in another part of ultrapure water to obtain a mineral water solution;
(3) Adding vitamin emulsion into polyphenol water solution, performing ultrasonic treatment, adding mineral water solution, mixing, centrifuging, and collecting upper emulsion to obtain polyphenol-based vitamin complex.
Aiming at water-soluble vitamins, the preparation method of the polyphenol-based vitamin complex comprises the following steps:
(1) Adding vitamins into a phosphate buffer solution to form a vitamin solution;
(2) Dissolving plant polyphenol in ultrapure water to form a polyphenol water solution; and will containZn 2+ Or Fe 2+ Dissolving the soluble salt in another part of ultrapure water to obtain a mineral water solution;
(3) Adding a vitamin solution into a polyphenol water solution, and stirring at room temperature to ensure that the vitamin is fully contacted with the plant polyphenol to form nanoparticles by agglomeration; then adding mineral water solution, stirring well, dialyzing the obtained solution under low concentration phosphate buffer solution for 2 days to remove impurities, and cutting off 3.0kDa of molecular weight; and freeze-drying the obtained polyphenol-based vitamin compound solution to prepare polyphenol-based vitamin compound dry powder.
In the method, the plant polyphenol is a plant secondary metabolite, the molecular structure contains a large amount of pyrogallol and catechol groups, and the plant polyphenol has the characteristic of strong complexation with metal ions. The network structure Material (MPN) composed of metal ions and plant polyphenol is a nano delivery platform with great potential, the preparation process is simple and rapid, and the network structure material has the characteristic of modularized raw material selection. It contains multiple edible plant polyphenols and multiple metal ions (mineral: ferrous ion Fe) 2+ Zinc ion Zn 2+ Etc.) may be selected. Plant polyphenols, also known as plant tannins, have long been used as tanning agents in the tanning industry. The leather tanning process is a process for crosslinking phenolic hydroxyl of plant polyphenol with skin collagen. The collagen is a kind of protein, so the plant polyphenol and the protein can be strongly combined, namely the plant polyphenol and the protein of the intestinal wall cell can be strongly combined through hydrogen bonds. The phenolic hydroxyl and aromatic group of the plant polyphenol can interact with different functional groups in various modes such as hydrogen bond, chelation, amphipathy, pi-pi superposition and the like. Therefore, MPN formed by complexing plant polyphenol and metal ions can be combined with vitamin molecules, and on the other hand, the metal ions in the structure can be simultaneously used as a mineral source for nutrition supplement. Based on the method, the plant polyphenol and the metal ions are used for modifying vitamin molecules, and the interaction of the plant polyphenol and the surface protein of intestinal wall cells is used for enhancing the absorption of vitamins and minerals.
Compared with the prior art, the invention has the advantages that:
(1) The modification of vitamins by the metal-polyphenol network material MPN can prolong the retention time of the vitamins in intestinal tracts.
(2) Modification of water-soluble vitamins by the metal-polyphenol network material MPN can form vitamin-containing nanoparticles, and can help absorption of vitamins compared with water-soluble small molecules. Meanwhile, the metal ions can be used as the supplement of minerals, so that the concentration of the metal ions in blood is increased, and the absorption of the mineral metal ions is promoted. Pharmacokinetics and biodistribution studies show that PVC can significantly prolong the retention and absorption time of vitamins in intestinal tracts. Blood concentration tests also show that the content of vitamins and minerals in blood is increased.
(3) The method for constructing the vitamin delivery carrier is a process of self-assembly of plant polyphenol and metal ions on the surface of the vitamin, and is convenient and rapid to operate.
Additional advantages, objects, and features of the invention will be set forth in part in the description which follows and in part will become apparent to those having ordinary skill in the art upon examination of the following or may be learned from practice of the invention.
Drawings
PVC prepared in FIG. 1, examples 1 and 2 E Oil-soluble vitamin model (a) and PVC C Transmission electron micrograph of water-soluble vitamin model (b).
FIG. 2 is a UV-visible diagram of a nutritional model for PVC water-soluble (a-e) and oil-soluble (f-g) vitamins.
FIG. 3, measurement of Zeta potential of PVC water-soluble (a) and oil-soluble (b) vitamin nutrition models.
FIG. 4 is a graph showing the particle size before and after vitamin modification.
Fig. 5, an anatomical diagram of the jejunum and ileum.
FIG. 6, pharmacokinetic analysis chart. In the figure: (a) -oil soluble vitamins, (b) -water soluble vitamins.
FIG. 7 comparison of iron content in blood 3h after feeding rat multivitamin mineral supplement and PVC multivitamin mineral supplement.
Detailed Description
The preferred embodiments of the present invention will be described in conjunction with the accompanying drawings, and it will be understood that they are described herein for the purpose of illustration and explanation and not limitation.
The plant polyphenol used in the following examples is epigallocatechin gallate (EGCG), tannic Acid (TA), rutin or anthocyanins. Epigallocatechin gallate is a typical plant polyphenol, is the main component of green tea polyphenol, and accounts for 40-60%. More and more studies have shown that EGCG has multiple biological functions, such as anti-inflammatory, antioxidant, immunomodulating, antitumor and modulating intestinal flora. Tannin is extracted from Galla chinensis, is hydrolyzed tannin, and has astringent and astringent effects. The molecular weight is about 1700, and the structure contains a plurality of pyrogallol groups. In medicine, gallic acid is a hemostatic astringent and has antibacterial effect. It has good reducibility, and can be used as antiseptic and antioxidant.
Example 1
Preparation of a polyphenol-based vitamin complex PVC:
mixing oil soluble vitamin E (or vitamin D, vitamin A) with EGCG and Fe 2+ Preparation of PVC by mixing E (or PVC) D 、PVC A ) Oil soluble vitamin nutrition model.
Dissolving vitamin E in soybean oil (with an equal volume ratio v: v = 1:1) to prepare an oil agent; treating the oil solution with KQ-100DE ultrasonic cleaner (Kunshan ultrasonic apparatus Co., ltd.) in phosphate buffer solution (0.05mmol, pH7.2) by ultrasonic wave (100W) for 180s to form VE emulsion; wherein the concentration of vitamin E is 5mgmL -1 . FeSO (ferric oxide) is added 4 ·7H 2 O(2.8mgmL -1 ) And EGCG (1 mgmL) -1 ) Dissolved in two portions of ultrapure water, respectively. Adding 1mLVE emulsion into 0.5mLEGCG aqueous solution, and performing ultrasonic treatment at 100W for 120s; then 27. Mu.L of Fe was added 2+ Solution of Fe 2+ The molar ratio to EGCG is 1:4; the total volume was made up to 2ml using PBS. Centrifuging the obtained solution (5000 r/min) for 5 min, and collecting the upper emulsion to obtain PVC E An emulsion.
The PVC oil-soluble vitamins marked by fluorescence are used for animal experiments to verify the vitamin absorption kinetics. Will fluoresceSubstance coumarin C6 (0.2mL, 1mgmL) -1 ) And 1mL vitamin A, D, E dissolved in 10mL dichloromethane stirring overnight; the solvent was removed using a rotary evaporator to give a fluorescently labeled vitamin A, D, E mixture. The PVC is then built up as described above ADE Oil-soluble vitamins.
Example 2
Preparation of a polyphenol-based vitamin complex PVC:
mixing water soluble VC (or VB2, VB5, VB9 and VB 12) with EGCG and Fe 2+ Preparation of PVC by mixing C A water-soluble vitamin nutrition model.
VC(5mg mL -1 ) Prepared with phosphate buffer (0.05mmol, pH 7.2) to obtain VC solution. Respectively reacting FeSO 4 ·7H 2 O(2.8mg mL -1 ) And EGCG (1 mg mL) -1 ) Dissolving in two portions of ultrapure water to obtain two aqueous solutions. The 1ml of lvc solution was added to the 0.5ml of gcg aqueous solution and stirred at room temperature for 30min to allow the vitamins to fully contact EGCG to agglomerate and form nanoparticles. Then 27. Mu.L of Fe was added 2+ Solution of Fe 2+ The molar ratio to EGCG was 1:4.Fe 2+ The agglomerated particles can be stabilized. The total volume was made up to 4ml using PBS. The resulting solution was dialyzed against a low concentration phosphate buffer (0.01mmol, pH 7.2) for 2 days to remove impurities (molecular weight cut-off 3.0 kDa). Then, PVC C The solution was prepared as a dry powder using a freeze-drying method.
The fluorescence labeled EGCG is used for constructing a PVC water-soluble vitamin nutrient substance model, and the fluorescein FITC labeled EGCG (or TA) is used. EGCG (or TA) (50 mg) and FITC (1 mg) were dissolved in 9mL of physiological saline and 1mL of phosphate buffer (0.05mmol, pH 9.0). FITC-labeled EGCG (TA) was dialyzed against PBS (0.01M, pH 7.2) in the dark for 2 days (molecular weight cut-off 3.0 kDa) and lyophilized to obtain. Then, the PVC water-soluble vitamin is constructed according to the method.
Comparative example
Preparation of vitamin mineral complex for control group:
mixing oil soluble vitamin emulsion (10 mgmL) -1 ) With a water-soluble vitamin solution (10 mgmL) -1 ) Mixing the mixture in a volume ratio of 1:1, adding FeSO 4 ·7H 2 O(2.8mgmL -1 ) 54 μ L of the solution. Stirring at room temperature for 1h, and lyophilizing to obtain powder, i.e. constructing common vitamin mineral complex of control group.
The properties are characterized as follows:
(1) Observation of PVC with Transmission Electron microscopy (TEM, thermoFisher scientific Inc., USA) E 、PVC C Vitamin nutrition model. As shown in FIG. 1, the negative-stained TEM photograph shows PVC E The oil-soluble vitamin model exhibits a core-shell structure, whereas PVC C The water-soluble vitamin model is irregular-shaped particles, and the irregular shape shows that the polyphenol-vitamin-metal particles form the composite nano particles.
(2) As shown in FIG. 2, the UV-visible spectrum (UV-Vis, thermoNanoDrop2000, USA) shows passage through EGCG-Fe 2+ The modification of the complex, the absorption peak of water-soluble and oil-soluble vitamins appears around 330nm, which proves that EGCG-Fe 2+ The complex forms a thin PVC shell on the surface of the vitamin.
(3) The results of the Zeta-potentiometer analysis are shown in FIG. 3, which shows the formation of a PVC skin on the vitamin surface. The Zeta potential values of the water-soluble vitamins are respectively reduced from-3.9 (VC), -14.6 (VB 2), -12.3 (VB 5), -12.4 (VB 9) and-5.2 (VB 12) to-9.2 (VC), -24.8 (VB 2), -18.4 (VB 5), -28.1 (VB 9) and-18.7 (VB 12); the Zeta potential value of the oil-soluble vitamin is reduced from-14.6 (VA), -15.8 (VD 3), -12.3 (VE) to-20.1 (VA), -24.8 (VD 3), -21.4 (VE). Through EGCG-Fe 2+ The modified nutrient, zeta potential, has shifted negatively in value because the polyphenol-metal complex has a more negative potential, changing the charge properties of the vitamin particle surface.
(4) Dynamic Light Scattering (DLS) test. FIG. 4 is a graph showing the particle size before and after vitamin modification. The figure (a) is oil-soluble vitamin A, (b) is vitamin D3, (c) is vitamin E, and (D) the water-soluble vitamin is EGCG-Fe 2+ And (4) characterizing the particle size before and after modification. As shown in the figure, the oil-soluble vitamin can be dispersed in water to form nano-scale colloidal particles with the particle sizes of 243 (VA), 239 (VD 3) and 242 (VE) nm respectively. Through EGCG-Fe 2+ After the modification, the particle size is not obviously changed, which indicates that EGCG-Fe 2+ A thin shell layer is formed on the surface of the oil-soluble vitamin. The water solution vitamin has no particle size in the solution, and EGCG-Fe is added 2+ Then, nanoparticles are formed, the particle size is 100-400nm, and EGCG-Fe is shown 2+ Reacts with water-soluble vitamins and is agglomerated to form particles.
(5) Animal experiments
To investigate the extended residence and absorption time of PVC vitamins, 2mL concentration 2mgmL -1 PVC of ADE The oil-soluble vitamins and the PVC water-soluble vitamins are mixed into a solution, the PVC mixed vitamins are prepared to be orally taken by healthy rats, and the rats are subjected to intragastric administration by taking the common mixed vitamins as a control group. Blood is drawn for 0-8h respectively for blood vitamin content detection. After 24h the rats were sacrificed and the gastrointestinal conditions were dissected. A part of rats are sacrificed at 2h for dissection, and 2-3 cm jejunal tissues are cut and fixed by 4% paraformaldehyde for morphology observation.
To evaluate the effect of PVC intake in vivo and taking into account the metabolism of vitamins, some rats were sacrificed after 2h of gavage, the gastrointestinal tract was dissected and the tissue morphology of the jejunum and ileum was observed at 2h (FIG. 5). The difference between PVC vitamins and ordinary vitamins in jejunum and ileum was significant at 2 h. The photographs of the dissection show that the PVC vitamins adhere to the mucosal side of the jejunum and ileum after 2 hours (the dark material in the figure shows the adhesion of the PVC complex nutrients to the intestinal wall). This was not observed in the group of rats receiving the common vitamins.
To further investigate the absorption of vitamins, we investigated the pharmacokinetics and biodistribution over 8 h. Tail blood was drawn every 2 hours after oral administration to healthy rats and the fluorescence concentration in plasma samples was determined. As shown in fig. 6, the time scale of the peak concentration of each PVC group in plasma was significantly longer than that of the corresponding unmodified vitamin group, while the area under the plasma concentration-time curve exceeding 8h was not reduced, which fully indicates that the absorption rate of the PVC-modified vitamin in the intestinal tract was significantly improved.
In order to explore the absorption effect of minerals in the PVC vitamins, oil-soluble vitamins and PVC water-soluble vitamins are mixed into PVC ADE Solution (2mL, 2mgmL) -1 ) And orally administered to healthy rats, and the rats were gavaged with normal vitamin mineral nutrients as a control group. Blood is drawn for 3h respectively for blood vitamin content detection. As shown in FIG. 7, by observing the blood concentration of rats fed the vitamin mineral complex supplement for 3 hours, it was found that the content of Fe in the plasma of the PVC group was significantly higher than that of the ordinary vitamin mineral complex group, which fully illustrates that the absorption rate in the intestinal tract is significantly improved by the PVC-modified vitamins and minerals.
Although the present invention has been described with reference to a preferred embodiment, it should be understood that various changes, substitutions and alterations can be made herein without departing from the spirit and scope of the invention as defined by the appended claims.
Claims (6)
1. A method for enhancing the absorption of vitamins and minerals in intestinal tracts is characterized in that plant polyphenol and minerals are complexed to form a nano-network material, the nano-network material is combined with vitamin molecules, and a polyphenol-based vitamin compound is formed through the wrapping or agglomeration adsorption; the polyphenol-based vitamin complex has long retention time in gastrointestinal tract, and can promote absorption of vitamins and minerals in gastrointestinal tract.
2. The method of enhancing the absorption of vitamins and minerals in the intestinal tract of claim 1 wherein said mineral is zinc ion Zn 2+ Or ferrous ion Fe 2+ 。
3. The method of claim 1, wherein the plant polyphenol is one or more of tannic acid, epigallocatechin gallate, rutin, and anthocyanins.
4. The method of enhancing the absorption of vitamins and minerals in the intestinal tract according to claim 1 wherein said vitamin is selected from the group consisting of oil soluble vitamin a, vitamin D, vitamin E, and mixtures of water soluble vitamin C, vitamin B2, vitamin B12, calcium pantothenate, folic acid, and mixtures of one or more thereof.
5. The method of enhancing the absorption of vitamins and minerals in the intestinal tract according to claim 4, wherein said polyphenol based vitamin complex is prepared for oil soluble vitamins by:
(1) Dissolving oil-soluble vitamins in soybean oil to prepare an oil agent, and adding the oil agent into a phosphate buffer solution for ultrasonic treatment to form a vitamin emulsion;
(2) Dissolving plant polyphenol in ultrapure water to form a polyphenol water solution; and will contain Zn 2+ Or Fe 2+ Dissolving the soluble salt in another part of ultrapure water to obtain a mineral water solution;
(3) Adding vitamin emulsion into polyphenol water solution, performing ultrasonic treatment, adding mineral water solution, mixing, centrifuging, and collecting upper emulsion to obtain polyphenol-based vitamin complex.
6. The method of claim 4, wherein the polyphenol based vitamin complex is prepared for a water soluble vitamin by:
(1) Adding water-soluble vitamins into a phosphate buffer solution to form a vitamin solution;
(2) Dissolving plant polyphenol in ultrapure water to form a polyphenol water solution; and will contain Zn 2+ Or Fe 2+ Dissolving the soluble salt in another part of ultrapure water to obtain a mineral water solution;
(3) Adding a vitamin solution into a polyphenol water solution, and stirring at room temperature to ensure that the vitamin is fully contacted with the plant polyphenol to form nanoparticles by agglomeration; then adding mineral water solution, stirring well, dialyzing the obtained solution under low concentration phosphate buffer solution for 2 days to remove impurities, and cutting off 3.0kDa of molecular weight; and freeze-drying the obtained polyphenol-based vitamin compound solution to prepare polyphenol-based vitamin compound dry powder.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211555869.3A CN115813882B (en) | 2022-12-06 | 2022-12-06 | Method for enhancing absorption of vitamins and minerals in intestinal tract |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211555869.3A CN115813882B (en) | 2022-12-06 | 2022-12-06 | Method for enhancing absorption of vitamins and minerals in intestinal tract |
Publications (2)
Publication Number | Publication Date |
---|---|
CN115813882A true CN115813882A (en) | 2023-03-21 |
CN115813882B CN115813882B (en) | 2024-08-09 |
Family
ID=85545221
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211555869.3A Active CN115813882B (en) | 2022-12-06 | 2022-12-06 | Method for enhancing absorption of vitamins and minerals in intestinal tract |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115813882B (en) |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2920015A (en) * | 1957-08-27 | 1960-01-05 | Armour & Co | Long-acting vitamin b12 |
US20070190209A1 (en) * | 2006-02-10 | 2007-08-16 | Mannatech, Inc. | All natural multivitamin and multimineral dietary supplement formulations for enhanced absorption and biological utilization |
AT504176A2 (en) * | 2006-08-16 | 2008-03-15 | Porta Lang & Klasnic Keg | BIOPOLYPHENOL-METAL ION COMPLEXES |
US20120093933A1 (en) * | 2010-10-17 | 2012-04-19 | Technion Research And Development Foundation Ltd. | Denatured lactoglobulin and polyphenol coassemblies |
CN103404594A (en) * | 2013-08-01 | 2013-11-27 | 浙江大学 | Functional milk with effect of prompting lead discharging and preparation method thereof |
CN105601701A (en) * | 2016-01-21 | 2016-05-25 | 中国农业大学 | Protein-polyphenol covalent compound and preparation method and application thereof |
EP3384780A1 (en) * | 2017-04-04 | 2018-10-10 | Noivita S.R.L.S. | Vegetable oil composition and uses thereof |
CN114642241A (en) * | 2022-04-01 | 2022-06-21 | 武汉轻工大学 | Composite plant polyphenol chelate and using method thereof |
US20220193200A1 (en) * | 2019-03-22 | 2022-06-23 | The Johns Hopkins University | Tannic acid/fe (iii) nanoparticles and methods of drug delivery |
-
2022
- 2022-12-06 CN CN202211555869.3A patent/CN115813882B/en active Active
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2920015A (en) * | 1957-08-27 | 1960-01-05 | Armour & Co | Long-acting vitamin b12 |
US20070190209A1 (en) * | 2006-02-10 | 2007-08-16 | Mannatech, Inc. | All natural multivitamin and multimineral dietary supplement formulations for enhanced absorption and biological utilization |
AT504176A2 (en) * | 2006-08-16 | 2008-03-15 | Porta Lang & Klasnic Keg | BIOPOLYPHENOL-METAL ION COMPLEXES |
US20120093933A1 (en) * | 2010-10-17 | 2012-04-19 | Technion Research And Development Foundation Ltd. | Denatured lactoglobulin and polyphenol coassemblies |
CN103404594A (en) * | 2013-08-01 | 2013-11-27 | 浙江大学 | Functional milk with effect of prompting lead discharging and preparation method thereof |
CN105601701A (en) * | 2016-01-21 | 2016-05-25 | 中国农业大学 | Protein-polyphenol covalent compound and preparation method and application thereof |
EP3384780A1 (en) * | 2017-04-04 | 2018-10-10 | Noivita S.R.L.S. | Vegetable oil composition and uses thereof |
US20220193200A1 (en) * | 2019-03-22 | 2022-06-23 | The Johns Hopkins University | Tannic acid/fe (iii) nanoparticles and methods of drug delivery |
CN114642241A (en) * | 2022-04-01 | 2022-06-21 | 武汉轻工大学 | Composite plant polyphenol chelate and using method thereof |
Non-Patent Citations (1)
Title |
---|
EUNYOUNG KIM ET AL.: "Ascorbic Acid Offsets the Inhibitory Effect of Bioactive Dietary Polyphenolic Compounds on Transepithelial Iron Transport in Caco-2 Intestinal Cells", THE JOURNAL OF NUTRITION, 31 May 2011 (2011-05-31), pages 828 * |
Also Published As
Publication number | Publication date |
---|---|
CN115813882B (en) | 2024-08-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Qiu et al. | Construction, stability, and enhanced antioxidant activity of pectin-decorated selenium nanoparticles | |
CN107412280B (en) | Nano-selenium hydrosol with anti-tumor activity, preparation and preservation method and application | |
CN111317135A (en) | Method for embedding slow-release curcumin by polyphenol-modified zein nanoparticles | |
CN111012760B (en) | Casein/anionic polysaccharide nano particle loaded with hydrophobic drug and nutrient and preparation method thereof | |
CN108850790A (en) | A kind of monascorubin microcapsules and preparation method thereof | |
CN113080452A (en) | High-load and high-stability protein-based curcumin product and preparation method and application thereof | |
CN115919801B (en) | Preparation method of tannic acid-zinc coordinated chitosan-selenium nanoparticle | |
CN111759822B (en) | Nano-selenium-zein composite nano-particles and preparation method thereof | |
CN108096214B (en) | Magnetotactic bacteria quantum dot microcapsule and preparation method thereof | |
US11684572B2 (en) | Methods for producing carboxylate ligand modified ferric iron hydroxide colloids and related compositions and uses | |
CN115813882B (en) | Method for enhancing absorption of vitamins and minerals in intestinal tract | |
CN115969041B (en) | Method for modifying nutrient substances by polyphenol-based nano particles | |
CN115777939B (en) | Iron supplementing oral liquid and preparation method thereof | |
CN109453265B (en) | Nano zinc green tea sustained release preparation wrapped by poly n-butyl cyanoacrylate and application thereof | |
CN105879051A (en) | Preparation and application of self-assembled nano-drug of core-shell structure | |
CN109069430A (en) | For increasing the composition and method of iron intake in the mammalian body | |
Yu et al. | Nanocarrier from water extract solution of Auricularia auricula for zinc delivery | |
CN103301090B (en) | Preparation method of genistein targeted nanometer particle | |
CN111888340B (en) | pH response slow-release selenoprotein composite nanoparticle and preparation and application thereof | |
Foujdar et al. | Fabrication of “Lysine modified Zein-Punica granatum peels’ purified ellagitannin nanoconjugates (Ly-MZ-PE NCs)” and in-vitro bio-accessibility, antiproliferative activity, and biosafety studies | |
CN102258791A (en) | Cyclodextrin/Fe3O4 magnetic nano composite and medicinal inclusion compound thereof | |
Zhu et al. | Construction, characterization and gastrointestinal digestion and absorption kinetics of the nanoparticles loaded with Malus baccata (Linn.) polyphenols | |
CN110200913B (en) | Preparation method of embedded sulbactam amoxicillin amide compound | |
TWI414316B (en) | Nano complexes | |
WO2021222898A1 (en) | Nutritional supplements comprising dietary metal complexes in a matrix of cellulosic materials |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |